| P50 | author | Christian Mølgaard | Q43062546 |
| | Signe Sparre Beck-Nielsen | Q58326297 |
| P2093 | author name string | K Brixen | |
| | J Gram | |
| P2860 | cites work | Pediatric DXA: technique and interpretation | Q24676076 |
| | A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets | Q28318629 |
| | New approaches for interpreting projected bone densitometry data | Q30982640 |
| | Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets | Q31928471 |
| | Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry | Q33213842 |
| | UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years | Q33255916 |
| | Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls | Q33474495 |
| | Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children | Q33526749 |
| | Changes in bone density during childhood and adolescence: an approach based on bone's biological organization | Q34227746 |
| | Bone's mechanostat: A 2003 update | Q34276207 |
| | Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype | Q34718202 |
| | A clinician's guide to X-linked hypophosphatemia | Q35167526 |
| | Whole body bone mineral content in healthy children and adolescents | Q35253937 |
| | Material matters: a mechanostat-based perspective on bone development in osteogenesis imperfecta and hypophosphatemic rickets. | Q36540213 |
| | Bone densitometry in Canadian children 8-17 years of Age. | Q36824646 |
| | Incidence and prevalence of nutritional and hereditary rickets in southern Denmark | Q37354625 |
| | The expanding family of hypophosphatemic syndromes | Q37968185 |
| | Increased bone mineral content in young adults with familial hypophosphatemic vitamin D refactory rickets | Q39969692 |
| | Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse | Q40683185 |
| | Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH). | Q42094408 |
| | Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets | Q43590072 |
| | X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features | Q44527260 |
| | Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets | Q46278613 |
| | Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate | Q46929321 |
| | Height, sitting height and leg length in patients with hypophosphataemic rickets | Q47242120 |
| | Growth in bone mass and size--are racial and gender differences in bone mineral density more apparent than real? | Q47289318 |
| | Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia | Q48054327 |
| | [Heights and weights of Danish children] | Q50555484 |
| | Body proportions of Danish children. Curves for sitting height ratio, subischial length and arm span | Q50556339 |
| | X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. | Q51618480 |
| | Assessment of Bone Quality by Quantitative Ultrasound of Proximal Phalanges of the Hand and Fracture Rate in Children and Adolescents with Bone and Mineral Disorders | Q52018149 |
| | Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. | Q54305276 |
| | Bone Response to Phosphate Salts, Ergocalciferol, and Calcitriol in Hypophosphatemic Vitamin D-Resistant Rickets | Q54546729 |
| | Phenotype Presentation of Hypophosphatemic Rickets in Adults | Q57727161 |
| | X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry | Q58086003 |
| | Clinical course of hypophosphatemic rickets in 23 adults | Q71047063 |
| | Long-term growth hormone treatment in children with renal hypophosphatemic rickets: Effects on growth, mineral metabolism, and bone density | Q72018632 |
| | Growth in familial hypophosphatemic vitamin-D-resistant rickets | Q72426619 |
| | DEXA bone densitometry measurements in adults with X-linked hypophosphatemia | Q72863129 |
| | Lumbar and radial bone mineral density in children and adolescents with X-linked hypophosphatemia: evaluation with dual X-ray absorptiometry | Q73604202 |
| | X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone | Q73763515 |
| | The rachitic bone | Q73920622 |
| | Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets | Q82680331 |
| | Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents | Q84230939 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2215-2221 | |
| P577 | publication date | 2013-02-07 | |
| P1433 | published in | Osteoporosis International | Q7107640 |
| P1476 | title | High bone mineral apparent density in children with X-linked hypophosphatemia | |
| P478 | volume | 24 | |